Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

165.67
Delayed Data
As of Jul 22
 +1.48 / +0.90%
Today’s Change
130.09
Today|||52-Week Range
181.81
+2.06%
Year-to-Date
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?
Jul 21 / Zacks.com - Paid Partner Content
Gilead (GILD) Stock Likely to Beat This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
Amgen (AMGN) Stock Rises on 'Non-Inferior' Late-Stage Trial Results
Jul 21 / TheStreet.com - Paid Partner Content
Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Jul 20 / MotleyFool.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG
Jul 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close164.19
Today’s open164.78
Day’s range164.00 - 166.33
Volume2,500,362
Average volume (3 months)2,933,806
Market cap$124.5B
Dividend yield2.41%
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+7.66%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.5
Price/Sales5.83
Price/Book4.45

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.69-0.79%
BIIBBiogen+5.33+1.89%
BAXBaxter International...+0.22+0.48%
CTLTCatalent Inc-0.45-1.82%
Data as of 4:01pm ET, 07/22/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$2.73
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs